A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B
Clinical trial NCT02332473 · COMPLETED
Trial details
- NCT number
- NCT02332473
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-02-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.